Event: BTOG 2024

BTOG 2024: networking highlights and insights

Key insights from BTOG 2024: MARS 2 and HIT-MESO

BTOG 2024 insights & future directions: a comprehensive approach to thoracic malignancies

BTOG Conference 2024 - Case Study

BTOG 2024 highlights: MARS 2 trial on mesothelioma surgery and TRACERx on lung cancer evolution

Reflecting on BTOG 2024: networking and multidisciplinary collaboration

Insights from BTOG 2024: advancements in TNM staging, systematic staging, & immunotherapy strategies

Exploring novel therapeutics in lung cancer: insights from BTOG 2024

Ongoing lung cancer trials and the potential of Trop2 biomarker at BTOG 2025

State of the Nation 2024 report: promising trends & challenges in lung cancer diagnosis & treatment

Addressing challenges in collecting cardiac toxicity data: NI-HEART analysis

2024: Meet the Farm (and newbies), Ren's health problems, Tog Spot Good Stuff and more!

Advancements in stent technology for treating central airway obstruction

Personalized treatment planning for lung cancer with interstitial lung disease

Ongoing trials in thoracic radiotherapy: evaluating current role and significance

Managing lung cancer in ILD patients and implementing ctDNA testing in the NHS

Is there a role for radiotherapy in extensive-stage SCLC?

NI-HEART study results: cardiotoxicity after lung cancer radiotherapy

Assessing treatment options for lung cancer with interstitial lung disease

Addressing malignant central airway obstruction

Implementing liquid biopsies: advancing lung cancer care in the UK

STABLE-MATES: sublobar resection vs SAbR in high-risk patients with stage I NSCLC

Managing lung cancer patients with ILD: the oncology perspective

Assessing vaccine delivery in lung cancer care

welcome to shbcf.ru